Jane Street
BXRX

Jane Street’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Jane Street’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27,342
Closed -$32K – 9763
2023
Q2 		$32K Buy
+27,342
New +$26.1K ﹤0.01% 8301
2022
Q2 		– Sell
-264
Closed -$19K – 11530
2022
Q1 		$19K Buy
264
+250
+1,786% +$46.1K ﹤0.01% 9962
2021
Q4 		$4K Buy
+14
New +$8.77K ﹤0.01% 9956
2020
Q3 		– Sell
-28
Closed -$164K – 8257
2020
Q2 		$164K Buy
+28
New +$134K ﹤0.01% 6493

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's BXRX Position: Q3 2023 in Review

Jane Street sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q3 2023, closing a stake of 27,342 shares — an estimated $32K sold.

Jane Street first reported a position in BXRX in Q2 2020 and held it in 4 quarters. The position peaked at $164K in Q2 2020. 15 funds tracked by Wall St. Rank hold BXRX as of Q3 2023.

  • Jane Street reported no remaining Baudax Bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 27,342 Baudax Bio, Inc. Common Stock shares in Q3 2023, an estimated $32K.
  • Jane Street first reported a position in Baudax Bio, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Jane Street's Baudax Bio, Inc. Common Stock position peaked at $164K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.